< Back to Search

Neurology® Podcast - July 7 2015 Issue

Switching from natalizumab to fingolimod: a randomized, placebo-controlled study of patients with RRMS

1) Switching from natalizumab to fingolimod in patients with remitting-relapsing multiple sclerosis and 2) Topic of the month: Plenary sessions AAN Meeting April 2015. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Ludwig Kappos about his paper on switching from natalizumab to fingolimod in patients with remitting-relapsing multiple sclerosis. Dr. Sarah Wesley is reading our e-Pearl of the week about dopamine-responsive dystonia. In the next part of the podc Read More

Download this Episode

Episode Segments

Introduction

00:17 00:50

Play Segment

Interview-Switching from natalizumab to fingolimod: a randomized, placebo-controlled study of patients with RRMS

ePearl 1-dopamine-responsive dystonia

LOTW-neurologists' burnout, cost and quality of healthcare, value of neurology to congress and payers along with maintenance of certification

ePearl 2-dopamine-responsive dystonia

Closing

35:49 36:26

Play Segment

Top

FOR MORE INFORMATION

Email pbaskin@neurology.org

Footer